Difference between revisions of "Gene Therapy versus Human Genome Editing (Biotechnology and Society 2016)"

From SynBioCyc
Jump to: navigation, search
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
 
 
[[File:AAV_Gene_Therapy.jpg|350px|thumb|right|Glybera ([http://en.wikipedia.org/wiki/Alipogene_tiparvovec Alipogene tiparvovec]) gene therapy]]
 
[[File:AAV_Gene_Therapy.jpg|350px|thumb|right|Glybera ([http://en.wikipedia.org/wiki/Alipogene_tiparvovec Alipogene tiparvovec]) gene therapy]]
 
 
==== [[Media:Gene_Therapy_Versus_Human_Germline_Modification_Pre-Discussion_Questions_2016F.docx| Download Pre-Discussion Questions (MS Word)]] ====
 
==== [[Media:Gene_Therapy_Versus_Human_Germline_Modification_Pre-Discussion_Questions_2016F.docx| Download Pre-Discussion Questions (MS Word)]] ====
 
 
==== [[Media:Policy_Czar_Template.docx | Download Policy Czar Template (MS Word)]] ====
 
==== [[Media:Policy_Czar_Template.docx | Download Policy Czar Template (MS Word)]] ====
 
  
 
== Everyone: Overview of gene therapy, germline modification, and genome synthesis ==
 
== Everyone: Overview of gene therapy, germline modification, and genome synthesis ==

Revision as of 13:47, 30 October 2016

Glybera (Alipogene tiparvovec) gene therapy

Download Pre-Discussion Questions (MS Word)

Download Policy Czar Template (MS Word)

Everyone: Overview of gene therapy, germline modification, and genome synthesis

Required Reading/Viewing

Additional Resources

CRISPR Germline Modification Czar

Required Reading/Viewing

Gene Therapy Czar

Required Reading/Viewing